NIAGARA FALLS, N.Y.--(BUSINESS WIRE)--Cabbacis (OTCQB: CABI), a U.S. federally-licensed tobacco- product manufacturer focused on harm-reduction products being developed under the iBlendâ"¢ brand name, today announced that management will attend the upcoming Noble Capital Markets October 2025 Emerging Growth Virtual Equity Conference, on October 8th and 9th 2025. Share About Cabbacis Cabbacis (OTCQB: CABI) is focused on commercializing groundbreaking, patented harm-reduction tobacco products for the world's ...